These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2883213)
1. Treatment of Barrett's esophagus with H2 blockers. Cooper BT; Barbezat GO J Clin Gastroenterol; 1987 Apr; 9(2):139-41. PubMed ID: 2883213 [TBL] [Abstract][Full Text] [Related]
2. Ranitidine therapy of Barrett's ulcer. Case report. Andersson R; Löwgren B Acta Chir Scand; 1986 Oct; 152():629-31. PubMed ID: 3811766 [TBL] [Abstract][Full Text] [Related]
3. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole. Lee FI; Isaacs PE Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644 [TBL] [Abstract][Full Text] [Related]
4. Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus. Delpre G; Kadish U; Glanz I; Avidor I Am J Gastroenterol; 1984 Jan; 79(1):8-11. PubMed ID: 6419585 [TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Wesdorp IC; Bartelsman J; Schipper ME; Tytgat GN Gut; 1981 Sep; 22(9):724-7. PubMed ID: 7297920 [TBL] [Abstract][Full Text] [Related]
9. Healing of chronic Barrett ulcers with omeprazole. Hameeteman W; Tytgat GN Am J Gastroenterol; 1986 Sep; 81(9):764-6. PubMed ID: 2875649 [TBL] [Abstract][Full Text] [Related]
10. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Sampliner RE; Garewal HS; Fennerty MB; Aickin M Dig Dis Sci; 1990 Jan; 35(1):93-6. PubMed ID: 1967235 [TBL] [Abstract][Full Text] [Related]
11. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Collen MJ; Johnson DA Dig Dis Sci; 1992 Apr; 37(4):570-6. PubMed ID: 1551347 [TBL] [Abstract][Full Text] [Related]
12. Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Neumann CS; Iqbal TH; Cooper BT Aliment Pharmacol Ther; 1995 Aug; 9(4):451-4. PubMed ID: 8527623 [TBL] [Abstract][Full Text] [Related]
13. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus. Humphries TJ J Clin Gastroenterol; 1987 Feb; 9(1):28-32. PubMed ID: 2881958 [TBL] [Abstract][Full Text] [Related]
16. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Sharma P; Sampliner RE; Camargo E Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303 [TBL] [Abstract][Full Text] [Related]
17. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506 [TBL] [Abstract][Full Text] [Related]
19. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist. Mohammed R; Mitchell KG; Mackay C Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237 [TBL] [Abstract][Full Text] [Related]
20. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study. Thota PN; Hajifathalian K; Benjamin T; Runkana A; Lopez R; Sanaka MR J Dig Dis; 2017 Mar; 18(3):143-150. PubMed ID: 28188977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]